Table 3.
KEGG pathway analysis of differentially expressed genes (downregulated) in lung adenocarcinoma
| Pathway ID | Name | Count | % | p-Value | Genes |
|---|---|---|---|---|---|
| ptr04080 | Neuroactive ligand-receptor interaction | 10 | 6.2 | 0.001298 | EDNRB, S1PR1, RXFP1, GRIA1, SSTR1, P2RY1, ADRA1A, CALCRL, VIPR1, GHR |
| ptr04514 | Cell adhesion molecules (CAMs) | 7 | 4.3 | 0.003249 | CLDN18, ITGA8, PECAM1, NTNG1, NFASC, JAM2, CDH5 |
| ptr04360 | Axon guidance | 6 | 3.7 | 0.008075 | SEMA5A, SEMA6A, SEMA6D, SEMA3G, NTNG1, SLIT2 |
| ptr05410 | Hypertrophic cardiomyopathy (HCM) | 5 | 3.1 | 0.009096 | ACE, SGCG, TNNC1, ITGA8, TTN |
| ptr04270 | Vascular smooth muscle contraction | 5 | 3.1 | 0.033494 | RAMP3, GUCY1A2, ADRA1A, CALCRL, PPP1R14A |